Valley surgeon heads up test of aneurysm treatment - Business First of Columbus:

borislavamcoc.blogspot.com
Rodriguez, the director of peripheral vascularr services at the ArizonaHeart Institute, has been namec the national principal investigator for the Phase II which is required by the to enroll 160 The Arizona Heart Institute is one of 14 centers involvec in the study nationwide. “We are lookinv to include at leasy six more centers to complete 20 centerw inthe U.S.,” Rodriguez said. The endoluminal grafft is manufactured bynear Glasgow, Scotland. Called the Anacondza Stent Graft System, it allows the surgeon to reposition the device once it has been placedx acrossthe aneurysm.
So far, nearly 4,0000 patients in Europe have received theAnacondaw device, but it must get approval from the FDA before it can be used in the U.S. Rodriguez said the minimally invasive procedure onthe study’sw first patient went well, saying the device is very easy to use. “He was up on his feet the next morningthaving breakfast,” Rodriguez said of the patient. “You can’tf do that when you open the chest. This eliminatesz the need for open heart Abdominalaortic aneurysm, or “ballooning” of the body’xs main artery, is a serious conditionn prone to rupture and lead to sudden Actor John Ritter died of an aortic ruptures in 2003.
Symptoms can occur suddenly with severe, sharp pain in the Patients who experience these symptoms should seek immediatemedical attention, Rodriguez Early detection can prevent sudden death. Patients with a family historu of aortic aneurysm or other connective tissue disorderd should notify their physician aboug their risk ofaortic aneurysm, he